Tomás Reinert
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Reinert, Tomas
LB1802, NCT03892655: Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer

Active, not recruiting
N/A
170
RoW
Libbs Farmacêutica LTDA
Breast Cancer
12/22
07/28
Binoto, Monique
LB1802, NCT03892655: Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer

Active, not recruiting
N/A
170
RoW
Libbs Farmacêutica LTDA
Breast Cancer
12/22
07/28

Download Options